Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area : a systematic review
Carrillo-Santisteve, Paloma ; Tavoschi, Lara ; Severi, Ettore ; Bonfigli, Sandro ; Edelstein, Michael ; Byström, Emma LU
and Lopalco, Pierluigi
(2017)
In The Lancet. Infectious Diseases
17(10).
p.306-319
- Abstract
Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevalence and susceptibility in the general population or special groups in the EU and EEA. We searched databases and public health national institutes websites for HAV seroprevalence records published between Jan 1, 1975, and June 30, 2014, with no language restrictions. An updated search was done on Aug 10, 2016. We defined seroprevalence profiles (very low, low, and intermediate) as the proportion of the population with age-specific anti-HAV antibodies at age 15 and 30 years, and susceptibility... (More)
Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevalence and susceptibility in the general population or special groups in the EU and EEA. We searched databases and public health national institutes websites for HAV seroprevalence records published between Jan 1, 1975, and June 30, 2014, with no language restrictions. An updated search was done on Aug 10, 2016. We defined seroprevalence profiles (very low, low, and intermediate) as the proportion of the population with age-specific anti-HAV antibodies at age 15 and 30 years, and susceptibility profiles (low, moderate, high, and very high) as the proportion of susceptible individuals at age 30 and 50 years. We included 228 studies from 28 of 31 EU and EEA countries. For the period 2000-14, 24 countries had a very low seroprevalence profile, compared with five in 1975-89. The susceptibility among adults ranged between low and very high and had a geographical gradient, with three countries in the low susceptibility category. Since 1975, EU and EEA countries have shown decreasing seropositivity; however, considerable regional variability exists. The main limitations of this study are that the studies retrieved for analysis might not be representative of all EU and EEA publications about HAV and might have poor national representativeness. A large proportion of EU and EEA residents are now susceptible to HAV infection. Our Review supports the need to reconsider specific prevention and control measures, to further decrease HAV circulation while providing protection against the infection in the EU and EEA, and could be used to inform susceptible travellers visiting EU and EEA countries with different HAV endemicity levels.
(Less)
- author
- Carrillo-Santisteve, Paloma
; Tavoschi, Lara
; Severi, Ettore
; Bonfigli, Sandro
; Edelstein, Michael
; Byström, Emma
LU
and Lopalco, Pierluigi
- author collaboration
- publishing date
- 2017-10
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Aging, Europe/epidemiology, European Union, Hepatitis A/blood, Humans, Seroepidemiologic Studies, Time Factors
- in
- The Lancet. Infectious Diseases
- volume
- 17
- issue
- 10
- pages
- 306 - 319
- publisher
- Elsevier
- external identifiers
-
- scopus:85020920058
- pmid:28645862
- ISSN
- 1474-4457
- DOI
- 10.1016/S1473-3099(17)30392-4
- language
- English
- LU publication?
- no
- additional info
- Copyright © 2017 Elsevier Ltd. All rights reserved.
- id
- c9c2d3ba-5e65-4312-866b-ca49137064d2
- date added to LUP
- 2024-04-29 11:31:34
- date last changed
- 2024-05-14 05:19:17
@article{c9c2d3ba-5e65-4312-866b-ca49137064d2,
abstract = {{<p>Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevalence and susceptibility in the general population or special groups in the EU and EEA. We searched databases and public health national institutes websites for HAV seroprevalence records published between Jan 1, 1975, and June 30, 2014, with no language restrictions. An updated search was done on Aug 10, 2016. We defined seroprevalence profiles (very low, low, and intermediate) as the proportion of the population with age-specific anti-HAV antibodies at age 15 and 30 years, and susceptibility profiles (low, moderate, high, and very high) as the proportion of susceptible individuals at age 30 and 50 years. We included 228 studies from 28 of 31 EU and EEA countries. For the period 2000-14, 24 countries had a very low seroprevalence profile, compared with five in 1975-89. The susceptibility among adults ranged between low and very high and had a geographical gradient, with three countries in the low susceptibility category. Since 1975, EU and EEA countries have shown decreasing seropositivity; however, considerable regional variability exists. The main limitations of this study are that the studies retrieved for analysis might not be representative of all EU and EEA publications about HAV and might have poor national representativeness. A large proportion of EU and EEA residents are now susceptible to HAV infection. Our Review supports the need to reconsider specific prevention and control measures, to further decrease HAV circulation while providing protection against the infection in the EU and EEA, and could be used to inform susceptible travellers visiting EU and EEA countries with different HAV endemicity levels.</p>}},
author = {{Carrillo-Santisteve, Paloma and Tavoschi, Lara and Severi, Ettore and Bonfigli, Sandro and Edelstein, Michael and Byström, Emma and Lopalco, Pierluigi}},
issn = {{1474-4457}},
keywords = {{Aging; Europe/epidemiology; European Union; Hepatitis A/blood; Humans; Seroepidemiologic Studies; Time Factors}},
language = {{eng}},
number = {{10}},
pages = {{306--319}},
publisher = {{Elsevier}},
series = {{The Lancet. Infectious Diseases}},
title = {{Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area : a systematic review}},
url = {{http://dx.doi.org/10.1016/S1473-3099(17)30392-4}},
doi = {{10.1016/S1473-3099(17)30392-4}},
volume = {{17}},
year = {{2017}},
}